What are the recommended drugs and dosages for treating iron deficiency anemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Drugs and Dosages for Iron Deficiency Anemia

Oral ferrous sulfate 200 mg twice daily is the first-line treatment for iron deficiency anemia due to its effectiveness, simplicity, and low cost. 1

Oral Iron Therapy

First-Line Oral Iron Options:

  • Ferrous sulfate: 200 mg twice daily (contains approximately 65 mg elemental iron per tablet) 1
  • Ferrous gluconate: 300 mg daily (contains 27-38 mg elemental iron per tablet) 1
  • Ferrous fumarate: 200 mg daily (contains 65-106 mg elemental iron per tablet) 1

Dosing Considerations:

  • Treatment should continue for 3 months after hemoglobin normalization to replenish iron stores 1
  • Lower doses may be equally effective and better tolerated in patients experiencing side effects 1
  • Hemoglobin should rise by approximately 2 g/dL after 3-4 weeks of therapy 1
  • Adding ascorbic acid (250-500 mg twice daily) may enhance iron absorption when response is poor 1

Monitoring:

  • Monitor hemoglobin and red cell indices at 3-month intervals for the first year after normalization, then after another year 1
  • Additional oral iron should be given if hemoglobin or MCV falls below normal 1

Intravenous Iron Therapy

Indications for IV Iron:

  • Intolerance to at least two oral iron preparations 1
  • Poor compliance with oral therapy 1
  • Clinically active inflammatory bowel disease 1
  • Hemoglobin below 10 g/dL 1
  • Patients after bariatric surgery (impaired absorption) 1
  • When iron loss exceeds oral iron absorption capacity 1

IV Iron Formulations:

  • Ferric carboxymaltose (Ferinject/Injectafer): 750-1000 mg per dose, can be given as single dose or two 750 mg doses one week apart 1

    • Special consideration: Risk of hypophosphatemia 1
  • Iron sucrose (Venofer): 200 mg per dose, given as 5 doses of 200 mg or 3 doses of 300 mg weekly 1

    • Can be administered over 10 minutes (bolus) 1
  • Ferric derisomaltose/iron isomaltoside (Monofer): 1000 mg as single dose 1

  • Low-molecular-weight iron dextran (Cosmofer): 20 mg/kg or 1000 mg as single dose 1

    • Can be given IV or IM (though IM is painful and requires multiple injections) 1
    • Requires test dose due to risk of anaphylactic reactions 1
  • Ferumoxytol (Feraheme): 510 mg per dose, given as two doses or single 1020 mg dose 1

    • Special consideration: Notify radiologist if MRI needed within 3 months of infusion 1

Dosing Based on Severity and Patient Weight

For IV iron dosing in inflammatory bowel disease patients 1:

  • Hemoglobin 10-12 g/dL (women) or 10-13 g/dL (men):

    • Weight <70 kg: 1000 mg
    • Weight ≥70 kg: 1500 mg
  • Hemoglobin 7-10 g/dL:

    • Weight <70 kg: 1500 mg
    • Weight ≥70 kg: 2000 mg

Special Considerations

  • Safety precautions: Resuscitation facilities should be available when administering IV iron due to risk of anaphylactic reactions 1
  • Cost implications: IV iron is substantially more expensive than oral formulations 1
  • Weekly dosing: Some evidence suggests weekly iron supplementation may improve compliance while maintaining efficacy 2
  • Tolerability: Extended-release formulations may improve adherence due to better gastrointestinal tolerability 3
  • Response assessment: If hemoglobin doesn't rise after 3-4 weeks, consider poor compliance, misdiagnosis, continued blood loss, or malabsorption 1

Pitfalls to Avoid

  • Insufficient treatment duration: Failing to continue iron therapy for 3 months after hemoglobin normalization can lead to recurrence 1
  • Overlooking underlying causes: Always treat the underlying cause of iron deficiency while supplementing iron 1
  • Diphenhydramine use during IV reactions: Should be avoided as its side effects can be mistaken for worsening of the reaction 1
  • Overestimating IV iron benefits: While initial hemoglobin rise is more rapid with IV iron, the hemoglobin at 12 weeks is similar to oral iron therapy 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Preventive strategy to control iron deficiency anemia in children and adults.

JPMA. The Journal of the Pakistan Medical Association, 2003

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.